Evidence-Based Approaches to Pharmacokinetic Dilemmas
Track:
Education Sessions (CE)
Program Code: 223-L01
Date: Tuesday, December 6, 2011
Time: 8:00 AM to 10:30 AM EST
Location:
La Nouvelle Orleans Ballroom, C, Level 2
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Brian Erstad, PharmD, Professor, University of Arizona
Dr. Erstad is currently a full Professor and Assistant Department Head in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. He is also a Center Investigator for the Center for Health Outcomes and Pharmacoeconomics Research and a co-director for the Arizona Clinical Research Training Program. His clinical responsibilities are performed at University Medical Center. Dr. Erstads research interests pertain to critical care medicine with an emphasis on patient safety and related outcomes research - he has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad was on the Board of Directors of the American Society of Health-System Pharmacists and has served on numerous committees and task forces for various organizations including AHRQ, USP, ISPOR, the Society of Critical Care Medicine and the American College of Chest Physicians. Dr. Erstad was the first pharmacist to receive the Society of Critical Care Medicines Shubin-Weil Master Clinician/Teacher Excellence in Bedside Teaching Award.
John Murphy, Pharm.D., Professor and Associate Dean, The University of Arizona College of Pharmacy, Tucson
I have made more than 250 presentations to groups of pharmacists and others, many of which related to pharmacokinetic dosing issues. I have taught a clinical pharmacokinetics course for about 25 years, conduct and publish research in the field, and have published four editions of the book Clinical Pharmacokinetics with ASHP.
Michael Winter
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
John Murphy, Pharm.D., Professor and Associate Dean, The University of Arizona College of Pharmacy, Tucson
I have made more than 250 presentations to groups of pharmacists and others, many of which related to pharmacokinetic dosing issues. I have taught a clinical pharmacokinetics course for about 25 years, conduct and publish research in the field, and have published four editions of the book Clinical Pharmacokinetics with ASHP.
Describe issues related to predicting renal function.
Determine and evaluate dosing regimens in patients with confounding issues, such as obesity, amputation, and spinal cord injury.
Determine appropriate monitoring parameters and target concentrations for a patient on vancomycin.
Develop dosing regimens using different approaches for patients with renal impairment.